Oura, Whoop Push Deeper Into Healthcare

The world’s top wearable makers are integrating healthcare into their product features and branding, aiming to bridge the gap between biometric tracking and clinical care

The metrics on your wearables are no longer just fun insights to explore, as top tech brands begin pushing deeper into mainstream healthcare to create personalized, data-driven plans.

Oura and Whoop are leading the charge, building partnerships with health platforms and revealing their commitment to healthcare beyond everyday biometric tracking.

Oura Gets In on the GLP-1 Boom

Through a partnership with Eli Lilly, smart ring maker Oura is providing free ring sizing kits to members of the pharmaceutical company’s digital health platform, LillyDirect.

The platform is known for offering disease-specific resources, access to independent healthcare providers and convenient pharmacy services, notably supporting those prescribed GLP-1 treatments.

GLP-1s are becoming near-ubiquitous, with global adoption projected to exceed 100 million people by 2030. According to the ring maker, over half of Oura members identify as having obesity or being overweight, with tens of thousands already logging their GLP-1 therapy use in the app.

Oura recently introduced GLP-1 Insights as part of its latest gen ring, a feature that lets members log medication doses, side effects, weight changes and related biometric data in one place, alongside Lab Uploads, which allows members to import lab results into the app and view blood biomarkers alongside their ring data.

“As more people use GLP-1 therapies, there’s an opportunity to better support the day-to-day habits that influence outcomes,” said Oura chief medical officer Dr. Ricky Bloomfield. “By integrating daily habits with real-time biometric insights, we can offer a more connected and personalized approach to support lasting results — not just in weight on the scale, but in how people feel and function every day.”

Whoop Aims to Equip Healthcare Workers

Whoop, the Boston-based maker of the world’s most popular screenless wearable, isn’t shying away from healthcare, either.

One of its latest moves is a new subsidy program for healthcare professionals,  including physicians, resident physicians, fellows, nurses, nurse practitioners, physician assistants, and other eligible licensed clinical professionals. Now through August 31, eligible providers can receive a 50% subsidy on new Whoop Life memberships and 12-month membership extensions.

The program is Whoop’s effort to help clinicians in physically and mentally demanding jobs better understand their strain and recovery, to in turn better understand how their day-to-day stressors impact their health.

The initiative builds upon Whoop’s strong presence in healthcare, with features like Whoop Advanced Labs blood testing, its recently launched Specialized Panels testing and the integration of electronic health records within the Whoop app.

Like Oura, Whoop is also looking to partner with healthcare platforms, recently announcing a collaboration with HealthEx to connect medical records and biometric data to deliver more personalized health insights.

The health platform will allow Whoop members to combine medical history with continuous biometric insights in one secure place, bridging the gap between wearable data and clinical information. Users will be able to put biometrics like recovery, strain, sleep and overall performance in context with major health factors such as chronic conditions, recent procedures or medication changes to access more personalized recommendations that reflect a broader health profile.

Members have the power to choose whether to connect their medical records, and can see exactly what data is shared, with the option to disconnect at any time.

“Whoop members track their health in incredible detail, and that data can be transformative when paired with their full medical record,” said HealthEx co-founder and CEO Dr. Priyanka Agarwal. “Bringing comprehensive health history into the Whoop experience, alongside daily recovery, strain, and performance metrics, gives members a complete picture of their health. That’s the foundation for personalized, consumer-driven care that puts people in control, meeting them where they are already managing their health.”

The partnership with HealthEx reflects Whoop’s broader shift toward more connected, personalized health technology that leans into healthcare — something that until recently got the brand into a bit of regulatory trouble.

Last year, Whoop clashed with the U.S. Food and Drug Administration, which warned the company that its Blood Pressure Insights (BPI) feature cannot be legally marketed without regulatory clearance, arguing BPI qualifies as a medical device under federal law and lacks required premarket authorization.

But the tide has shifted, as the FDA recently dropped its enforcement against Whoop with planned changes to the BPI feature. In a closeout letter written to Whoop dated June 17, the agency said it “does not intend to enforce the device statutory and regulatory requirements for your product as modified.”

The brand plans to alter the feature in an upcoming software update, changing the BPI design that previously insinuated diagnostic categories of blood pressure, now shown “without discreet classifications.”